ATG-101 Is a Tetravalent PD-L1×4-1BB Bispecific Antibody That Stimulates Antitumor Immunity through PD-L1 Blockade and PD-L1-Directed 4-1BB Activation.
Yuwen H, Wang H, Li T, Ren Y, Zhang YK, Chen P, Sun A, Bian G, Li B, Flowers D, Presler M, Subramanian K, Xue J, Wang J, Lynch K, Mei J, He X, Shan B, Hou B.
Yuwen H, et al. Among authors: flowers d.
Cancer Res. 2024 May 15;84(10):1680-1698. doi: 10.1158/0008-5472.CAN-23-2701.
Cancer Res. 2024.
PMID: 38501978
Free PMC article.